When Carl and Ross met in 2018, they shared a vision of using technology to tackle chronic kidney disease.
They knew that this global health problem wasn’t talked about outside of clinical settings. And they wanted to make a future where self-managed care gave people the power to prevent the progression of CKD.
This vision has a far-reaching impact. Managed correctly, CKD patients may never need dialysis or a transplant. Self-care can help healthcare systems around the world save millions of dollars in sunk costs, taking the strain off medical services and families alike.
Fast forward to 2020 and the KAREL team is now laser-focused on their mission to prevent anyone with CKD from ever needing dialysis or a transplant.